Literature DB >> 16335992

Metabonomic study on the biochemical profiles of a hydrocortisone-induced animal model.

Minjun Chen1, Liping Zhao, Wei Jia.   

Abstract

This work describes the metabonomic study of a biochemical modification in vivo induced by high dose of hydrocortisone, which led to a unique pathologic condition similar to the 'kidney deficiency syndromes', an early stage of obesity and diabetes in traditional Chinese medicine. The methodology of the metabonomic approach consisted of GC/MS and multivariate statistical technique for the establishment of urine metabolic patterns of the treatment rats. In the study, 24-h urine was collected pre-dose and at days 1, 3, 7, and 10 post-dose after rats were injected with hydrocortisone at 1.5 mg/100 g. The acquired data were transferred into Matlab to be processed using principal components analysis (PCA). The results indicated that clear and consistent biochemical changes following hydrocortisone intervention under controlled conditions could be identified using chemometric analysis. The work suggests that this metabonomic approach could be used as a potentially powerful tool to investigate the biochemical changes of certain physiopathologic conditions such as metabolic syndrome, as an early diagnostic means.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16335992     DOI: 10.1021/pr050158o

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  19 in total

1.  Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry.

Authors:  Eric Chun Yong Chan; Kishore Kumar Pasikanti; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2011-09-08       Impact factor: 13.491

Review 2.  Application of metabonomic analytical techniques in the modernization and toxicology research of traditional Chinese medicine.

Authors:  Yong-Min Lao; Jian-Guo Jiang; Lu Yan
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

3.  An integrated metabonomic and proteomic study on Kidney-Yin Deficiency Syndrome patients with diabetes mellitus in China.

Authors:  Ning Jiang; Hong-fang Liu; Si-di Li; Wen-xia Zhou; Yong-xiang Zhang; Qi Zhang; Xian-zhong Yan
Journal:  Acta Pharmacol Sin       Date:  2015-05-04       Impact factor: 6.150

4.  Bridging the traditional Chinese medicine pattern classification and biomedical disease diagnosis with systems biology.

Authors:  Ai-ping Lu; Zhao-xiang Bian; Ke-ji Chen
Journal:  Chin J Integr Med       Date:  2012-12-13       Impact factor: 1.978

5.  Application of metabolomics technology in the research of Chinese medicine.

Authors:  Ping Liu; Ping Wang
Journal:  Chin J Integr Med       Date:  2014-04-03       Impact factor: 1.978

Review 6.  Isolation and analysis of ginseng: advances and challenges.

Authors:  Lian-Wen Qi; Chong-Zhi Wang; Chun-Su Yuan
Journal:  Nat Prod Rep       Date:  2011-01-24       Impact factor: 13.423

Review 7.  Study on correspondence between prescription and syndrome and the essence of phlegm and blood stasis syndrome in coronary heart disease based on metabonomics.

Authors:  Xiao-yan Lu; Hao Xu; Geng Li; Tie Zhao
Journal:  Chin J Integr Med       Date:  2012-12-03       Impact factor: 1.978

8.  A serum metabolomic investigation on lipoprotein lipase-deficient mice with hyperlipidemic pancreatitis using gas chromatography/mass spectrometry.

Authors:  Maochun Tang; Gouyong Hu; Yan Zhao; Mingming Su; Yuhui Wang; Wei Jia; Yunping Qiu; George Liu; Xingpeng Wang
Journal:  Biomed Rep       Date:  2013-03-12

9.  Application of metabolomics in traditional chinese medicine differentiation of deficiency and excess syndromes in patients with diabetes mellitus.

Authors:  Tao Wu; Ming Yang; Hua-Feng Wei; Song-Hua He; Shun-Chun Wang; Guang Ji
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-13       Impact factor: 2.629

10.  Metabolic profiling study of yang deficiency syndrome in hepatocellular carcinoma by h1 NMR and pattern recognition.

Authors:  Xueqiang Huang; Qunwei Chen; Genjin Yang; Weixing Dai; Qingbo Lang; Juan Du; Shikai Yan; Weidong Zhang; Changquan Ling
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.